Журнал кардиореспираторных исследований 2026. №2/3

Maqola mavzusi

The significance of immunocorrective therapy in the treatment of non-specific ulcerative colitis (60-62)

Mualliflar

D.E. Nosirova, A.D. Dusanov.

Muassasa

Samarqand davlat tibbiyot universiteti

Annotatsiya

Ulcerative colitis (UC), historically referred to as non-specific ulcerative colitis, is a chronic inflammatory disease of the colon characterized by relapsing and remitting mucosal inflammation. Despite significant advances in conventional therapy, including aminosalicylates, corticosteroids, and immunosuppressants, many patients continue to experience persistent symptoms, frequent exacerbations, and reduced quality of life. In this context, immunocorrective therapy has emerged as a promising direction aimed at restoring immune system balance rather than merely suppressing inflammation.

Kalit so'zlar

corticosteroid, conventional treatment, immune system, inflammation.

Adabiyotlar

1. Dusanov D.D., N.N. Mamurova «Clinical immunological characteristics of non-specific ulcerative colits» Journal of Critical Reviews Vol 7, Issue 4, 2020. Page 431-433 2. P. Zakiryaeva, N. Mamurova, D. Nosirova "Role of immunocorrective therapy in ulcerative colitis (https://cyberleninka.ru/article/n/rol- immunokorregiruyuschey-terapii-for- of non-specific ulcerative colitis)"Society and Innovations Magazine 2020, Pages 630-636 3. Dusanov A.D., N. N. Mamurova "Clinical and immunological parallels of non-specific ulcerative colitis. 4. Mamurova N. N. Dusanov A.D. "Clinical and immunological characteristics of non-specific ulcerative colitis (https://cyberleninka.ru/article/n/kliniko-immunologicheskaya-harakteristika-nespetsificheskogo-yazvennogo-kolita)» Journal of Achievements in Science and Education 2020 Issue 5 - (59) pages 65-68 5. Parfenov A. I. Antibiotic-associated intestinal dysbiosis. Pharmateka. 2013; 6: 87-9 6. Носирова Д. Э. Значение иммунокоррегирующей терапии при лечении неспецифического язвенного колита //World of Scientific news in Science. – 2024. – Т. 2. – №. 6. – С. 93-98. 7. Poluektova E. A., Kuchumova S. Yu., Ivashkin V. T. Application of the combined drug alverin citrate and semitikon in the treatment of patients with irritable bowel syndrome. Russian Journal of Gastroenterology, Hepatology, and Coloproctology. 2012; 4: 38- 8. Dusanov A.D. Clinical and immunological characteristics of ulcerative colitis. Abstract. Samarkand 1993 9. Закирьяева П., Мамурова Н., Носирова Д. Роль иммунокоррегирующей терапии при неспецифическом язвенном колите //Общество и инновации. – 2020. – Т. 1. – №. 1/S. – С. 630-636. 10. Obraztsov V.P. To the general symptomatology of enteritis and colitis. Russkiy arkhiv patologii, klinicheskoy meditsiny I bakteriologii. 1896; 1:285-93. (in Rusian) 11. Parfenov A.I. Diagnosis and treatment of enteropathy. Russkiy meditsinskiy zhurnal. 2013; 13; 731-6. (in Rusian). 12. Parfenov A.I. Enterology. Moscow; 2002. (in Rusian) 13. Tsimmerman Ya. S. Celiacia and hypolactasia in adults: etiology, pathogenesis, diagnostics and treatment. Klinicheskaya meditsina. 2011; 2: 14-20. (in Rusian) 14. Rapoport S.I. Functional diseases from the perspective of V.H. Vasilenko. Klinicheskaya meditsina. 2012; 9: 35-7. (in Rusian) 15. Kashkina E.I. Analysis of laboratory parameters in patients with non-specific ulcerative colitis. Bulletin of medical Internet conferences. 2014;1000 ID: 2014-08-8-A-4084 (in Russ). 16. Yoshida H., Granger N. D. Inflammatory bowel disease: a paradigm for the link between coagulation and inflammation. Inflammatory Bowel Diseases. 2009;15(8):1245–1255. 17. Arivarasu N. Anbazhagan, Shubha Priyamvada, Waddah A. Alrefai & Pradeep K. Dudeja (2018) Pathophysiology of IBD associated diarrhea, Tissue Barri-ers, 6:2. 18. Dignass A, Lindsay JO, Sturm A, et al. Second European evidencebased consensus on the diagnosis and management of ulcerative colitis part 2: current. J Crohn’s Colitis. 2012 Dec;6(10):991-1030. doi: 10.1016/j.crohns.2012.09.002 19. Dusanov A.D., Yuldasheva D.A. CLINICAL IMMUNOLOGICAL CHARACTERISTICS OF NON-SPECIFIC ULCERATIVE COLITIS. Journal of cardiorespiratory research. 2022, vol 3, issue 2, pp 20. Hao Ding, Xiao-Chang Liu, Qiao Mei, et al. Ulcerativa colitis flair induced by mesalazine suppositories hypersensitivity. World J Gastroenterol. 2014 Apr 7. doi: 10.3748/wjg.v20.i13.3716